http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110157406-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y30-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K11-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K11-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y30-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y20-00
filingDate 2019-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110157406-B
titleOfInvention Near-infrared quantum dot probe for tracing brain glioma
abstract The invention provides a near-infrared quantum dot probe traced by brain glioma, which is prepared by taking carboxylated poloxamer, cyclic glycyl-arginyl-glycyl-aspartyl-asparaginyl-proline short peptide and grafted poloxamer as materials, wrapping near-infrared quantum dots and cysteine-alanine-glutamine-lysine tetrapeptide, and self-assembling the materials in an aqueous solution to form nano micelles so as to form a solution of the near-infrared quantum dot probe specifically combined with integrin alpha v beta 3 overexpressed by brain glioma cells. The near-infrared quantum dot probe has the characteristics of uniform particle size, high stability, good tumor targeting property and strong tissue penetrability, and can open the blood brain barrier by combining the reversibility of an ultrasonic targeted microbubble explosion technology, thereby realizing high-efficiency, targeted and specific brain glioma tracing.
priorityDate 2019-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448844975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415810375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID80170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453047884
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465073220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161109573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9895205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524163

Total number of triples: 46.